Press Releases

UsAgainstAlzheimer’s is Driving Across-the-Board Global Momentum to Find an Alzheimer’s Cure at the Alzheimer’s Association International Conference in Toronto

July 22, 2016

TORONTO, July 22, 2016—As the Alzheimer’s Association International Conference (AAIC) kicks off, UsAgainstAlzheimer’s (UsA2) will be an active participant across a number of fronts, spanning research, clinical trial recruitment, minimizing disparities and improving caregiver support, adding its voice among international investigators, clinicians and care providers to advance science and see critical dementia breakthroughs come to fruition.

WomenAgainstAlzheimer’s Submits Testimony to Senate Finance Committee, Subcommittee on Health, Urging Members to Support Current and Future Legislation that Aids Alzheimer’s Patients and Caregivers

July 13, 2016

WASHINGTON, DC, July 13, 2016—Following a Senate Finance Committee, Subcommittee on Health, briefing, “Alzheimer’s Disease: The Struggle for Families, a Looming Crisis for Medicare,” WomenAgainstAlzheimer’s (WA2), an UsAgainst’Azheimer’s network, submitted a statement for the record, outlining the impact of Alzheimer’s disease on women, emphasizing the need for sex and gender differentiated research, as well as asking

UsAgainstAlzheimer’s Applauds Legislation to Support Caregivers of Medicare Beneficiaries with Alzheimer’s; Greater Urgency is Required to Meet the Needs of Growing Caregiver Population

July 7, 2016

With today’s introduction of the Alzheimer’s Beneficiary and Caregiver Support Act in the U.S. Senate and U.S. House of Representatives, UsAgainstAlzheimer’s applauds Senators Shelly Moore Capito (R-WV) and Debbie Stabenow (D-MI), as well as Representatives Linda Sanchez (D-CA) and Peter Roskam (R-IL), for recognizing the destructive emotional and physical tolls that Alzheimer’s disease has on the millions of caregivers in the United States, as well as its ballooning cost to Medicare and Medicaid.

UsAgainstAlzheimer’s Applauds House Subcommittee for Increasing Alzheimer’s Research Funding by $350 Million

July 7, 2016

A U.S. House subcommittee has approved an appropriations bill containing a $350 million increase in funding for Alzheimer’s disease research, a vital step in the national effort to prevent and effectively treat by 2025 an illness currently afflicting over 5.4 million Americans.

UsAgainstAlzheimer’s Urges House Passage of Proposed Labor-HHS Funding Bill Containing Increase for Alzheimer’s Research

July 6, 2016

The House Appropriations Committee has released its proposal for a fiscal year 2017 Labor, Health and Human Services funding bill that includes a $350 million increase for Alzheimer’s disease research funding, a move strongly supported today by the UsAgainstAlzheimer’s organization.

Why 2020?

UsAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.